Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07805876Not yet recruiting
Randomised trial of ciprofol in intracranial tumor (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of postoperative delirium at 5 days. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07805876.